In summary, we have shown that LGR5 is expressed by ES, in particular by putative cancer stem cells and, in the context of a Wnt and RSPO-rich microenvironment, LGR5 functions to potentiate canonical Wnt/β-catenin signaling. The gene discussed is LGR5; the disease is cancer.